Page 5,677«..1020..5,6765,6775,6785,679..5,6905,700..»

CVS/pharmacy Launches Revamped Gold Emblem Line, Featuring Enhanced Ingredients, New Snack Options and More Flavors

Posted: Published on February 21st, 2013

WOONSOCKET, R.I., Feb. 21, 2013 /PRNewswire/ --Shoppers looking for great-tasting snacks for the entire family will be delighted to try the satisfying additions and enriched flavors and variations of the revamped Gold Emblem line, available exclusively at CVS/pharmacy stores nationwide. The popular line, which includes a wide variety of snacks, dessert items, beverages and groceries, has undergone a vast array of changes to offer customers more options, even better taste and a contemporary new look. Among the more than 250 products included in the line are nuts, trail mixes, chips, pretzels, dried fruits, candies, cookies, spices, juices, condiments, baking essentials and breakfast bars. (Logo: http://photos.prnewswire.com/prnh/20100816/NE50800LOGO) Introduced in 1995, Gold Emblem was one of the first private brand food lines created by a major drugstore chain. Since that initial launch, the line has delivered great taste, uncompromising quality and unparalleled value for consumers and today is the number one brand in cookies, candy and nuts sold at CVS/pharmacy. Updates to the newly re-launched line include a contemporary identity and package re-design that embodies the commitment to meeting a very high taste standard, as well as a refined taste-test approval process used to evaluate every item that is branded with the Gold … Continue reading

Posted in Pharmacy | Comments Off on CVS/pharmacy Launches Revamped Gold Emblem Line, Featuring Enhanced Ingredients, New Snack Options and More Flavors

Pluristem Receives FDA Orphan Drug Status Designation for Treatment of Aplastic Anemia

Posted: Published on February 21st, 2013

HAIFA, Israel, Feb. 21, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the U.S. Food and Drug Administration (FDA) has designated Pluristem's PLacental eXpanded (PLX) cells orphan drug status for the treatment of aplastic anemia. Orphan drug designation qualifies a company for several benefits under the Orphan Drug Act of 1983 (ODA), as amended. These benefits include a 7-year period of orphan drug exclusivity upon product approval, a tax credit for certain clinical testing expenses for the orphan drug, written guidance on the non-clinical and clinical studies needed to obtain marketing approval of an orphan drug, and orphan drug grants. This is Pluristem's second orphan drug designation from the FDA. The company also received orphan drug status from the FDA for its PLX cells for the treatment of Buerger's disease in August of 2011. Aplastic anemia is a rare but serious disorder with a prevalence of less than 200,000 in the U.S. The disease is caused by the failure of hematopoietic stem cells (HSCs) contained within the bone marrow to produce red blood cells, white blood cells and platelets. The disease is considered an emergency and patients are supported … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Pluristem Receives FDA Orphan Drug Status Designation for Treatment of Aplastic Anemia

Stem cell 'homing' signal may help treat heart failure patients

Posted: Published on February 21st, 2013

Public release date: 21-Feb-2013 [ | E-mail | Share ] Contact: Maggie Francis Maggie.Francis@heart.org 214-706-1382 American Heart Association In the first human study of its kind, researchers activated heart failure patients' stem cells with gene therapy to improve their symptoms, heart function and quality of life, according to a study in the American Heart Association journal Circulation Research. Researchers delivered a gene that encodes a factor called SDF-1 to activate stem cells like a "homing" signal. The study is unique because researchers introduced the "homing" factor to draw stem cells to the site of injury and enhance the body's stem cell-based repair process. Generally, researchers extract and expand the number of cells, then deliver them back to the subject. "We believe stem cells are always trying to repair tissue, but they don't do it well not because we lack stem cells but, rather, the signals that regulate our stem cells are impaired," said Marc S. Penn, M.D., Ph.D., Director of Research at Summa Cardiovascular Institute in Akron, Ohio, and lead author and professor of medicine at Northeast Ohio Medical University in Rootstown, Ohio. SDF-1 is a naturally occurring protein, secreted by cells, that guides the movement of other cells. Previous … Continue reading

Comments Off on Stem cell 'homing' signal may help treat heart failure patients

Tarantula Treatment: Medicine’s Next Big Thing?

Posted: Published on February 21st, 2013

BACKGROUND: Duchenne muscular dystrophy (DMD) is a vicious form of muscular dystrophy that occurs mostly in boys. It is caused by an alteration in a gene, called the DMD gene that can be inherited, but it also can occur in people who do not have a known family history of the condition. The condition causes progressive loss of muscles function and weakness that begins in the lower limbs. Boys with DMD do not make the dystrophin protein in their muscles. It affects approximately one in 3500 boys worldwide. (Source: http://www.genome.gov) SYMPTOMS: When a child has DMD, symptoms normally appear before six years old and may appear as early as infancy. The first noticeable symptom is in motor milestones. For example, sitting and standing independently will be more of a challenge. The average age of walking in boys with DMD is 18 months. DMD attacks the leg and pelvic muscles, resulting in a waddle and difficulty climbing stairs. Calf muscles usually enlarge and the muscle tissue eventually is replaced with connective tissue and fat. When the leg muscles contract, the muscles become unusable because the muscle fibers are shortened and fibrosis occurs in connective tissue. Symptoms are usually prevalent in boys … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Tarantula Treatment: Medicine’s Next Big Thing?

California School Nurses Receive Critical Epilepsy Education

Posted: Published on February 21st, 2013

Epilepsy Foundation of Greater Los Angeles partners with California School Nurses Organization to bring critical epilepsy education to school nurses San Diego, CA (PRWEB) February 20, 2013 The sessions provided an opportunity to learn about the basics of epilepsy/seizures, seizure first aid and safety, current treatments, and the impact of epilepsy and/or treatments on learning, behavior and mental health. Videos of the more common types of seizures experienced by students were shown so school nurses would be better able to recognize seizures. There were also updates on Diastat in the school, and best practices around developing seizure action plans and the key elements for training teachers and other school personnel. A childs only job is to learn. Susan Pietsch-Escueta, Executive Director of the Epilepsy Greater Los Angeles emphasized during her opening remarks and later expanded on this to say that, school nurses have an important role in helping to ensure the students safety and well-being in order to optimize their learning experience. Partnering to improve the safety and well-being of students with epilepsy in California included: Dr. Sonya Wang, an assistant professor of neuroscience at UC San Diego and pediatric neurologist at Rady Childrens Hospital, gave an overview on Students … Continue reading

Comments Off on California School Nurses Receive Critical Epilepsy Education

Bill would require insurance to cover children with autism

Posted: Published on February 21st, 2013

Emma Guitard, and her father J.D. play together on an iPad Six-year-old Emma Guitard loves the color pink, the "Backyardigans" cartoon show, and her family. "She is a sweetheart. She is so loving," says her mother, Christy Guitard. "She will give you a smile, a hug, and a kiss." Guitard says her daughter is also a hard worker when it comes to her treatment. Emma started showing signs of autism around the time she turned a year old, and doctors diagnosed her soon after. Non-verbal, and requiring help with many daily tasks, Guitard says Emma falls on the more severe end of the autism spectrum. Doctors instructed Guitard to have her daughter in therapy at least 40 hours each week. The family soon learned how much that would cost them. "I was very shocked to find out that our insurance, which is a very good insurance plan through my husband's work, but it did not provide any coverage at all for autism," Guitard said. She says her family is covered under Blue Cross, Blue Shield. She says the plan will allow Emma 30 combined speech and occupational therapy visits per year, far less than the doctor's order. That help comes … Continue reading

Comments Off on Bill would require insurance to cover children with autism

Anonymous survey launched for Parkinson’s patients to collect data for research to help determine the cause of …

Posted: Published on February 21st, 2013

The Parkinson's Database Coalition has released an anonymous survey for Parkinson's patients to complete online. The data collected will provide researchers and doctors with important information to aid in diagnosis, treatment, prevention, finding the cause and possibly a cure for this disease. Yelm, Wa (PRWEB) February 20, 2013 The survey is for Parkinsons patients or caregivers to complete. It covers several detailed aspects not normally acquired in a clinical setting such as certain demographics, diet, types of treatments, work and chemical exposure. The survey has 115 questions. It will be supplemented by additional surveys which will generate more specific questions based on the data received. Once sufficient data is accumulated from the survey it will become available to researchers and physicians in a searchable database to aid in faster diagnosis, prevention, better treatment options and hopefully a cure. The focus of this survey is to isolate specific causes of Parkinsons disease based on accumulation of a large amount of data received directly from the patients themselves. Because the survey is anonymous it will allow Patients to retain privacy while providing valuable data for research. There are forums available with an anonymous Parkinsons Database Coalition I.D. to allow communications between the … Continue reading

Posted in Parkinson's Treatment | Comments Off on Anonymous survey launched for Parkinson’s patients to collect data for research to help determine the cause of …

Deep Brain Stimulation Clinic Expedites Patient Treatment at Muhammad Ali Parkinson Center

Posted: Published on February 21st, 2013

PHOENIX, Feb. 20, 2013 /PRNewswire/ --The Muhammad Ali Parkinson Center in Phoenix has launched a new clinic aimed at streamlining the process for the growing number of patients who are potential candidates for Deep Brain Stimulation. Deep Brain Stimulation (DBS) is a surgical treatment involving the implantation of a medical device called a "brain pacemaker," which sends electrical impulses to specific parts of the brain. DBS in select brain regions has provided remarkable therapeutic benefits for otherwise treatment-resistant movement and affective disorders such as Parkinson's disease, tremor and dystonia. The new clinic, which is part of the Ali center at the Barrow Neurological Institute, offers patients a comprehensive resource for education, medical evaluation, psychological assessment, imaging, surgery and post surgical monitoring. The one-day a week clinic was launched in July to serve the increasing numbers of patients who travel from all over the nation for DBS evaluation and surgery. "We have dramatically reduced the waiting and evaluation time for patients," says Rohit Dhall, MD, who heads the clinic. "In the past, waiting for evaluation and approval for this treatment could be frustrating for patients. So, we have added new resources to the Ali center and established this clinic. It has … Continue reading

Posted in Parkinson's Treatment | Comments Off on Deep Brain Stimulation Clinic Expedites Patient Treatment at Muhammad Ali Parkinson Center

Fish oil may help protect brain after stroke

Posted: Published on February 21st, 2013

Washington, February 21 (ANI): Triglyceride lipid emulsions rich in an omega-3 fatty acid injected within a few hours of an ischemic stroke can decrease the amount of damaged brain tissue by 50 percent or more in mice, according to a new study. The results obtained by researchers at Columbia University Medical Centre suggest that the emulsions may be able to reduce some of the long-term neurological and behavioral problems seen in human survivors of neonatal stroke and possibly of adult stroke, as well. Currently, clot-busting tPA (recombinant tissue-type plasminogen activator) is the only treatment shown to improve recovery from ischemic stroke. If administered soon after stroke onset, the drug can restore blood flow to the brain but may not prevent injured, but potentially salvageable, neurons from dying. Drugs with neuroprotective qualities that can prevent the death of brain cells damaged by stroke are needed, but even after 30 years of research and more than 1000 agents tested in animals, no neuroprotectant has been found effective in people. Omega-3 fatty acids, commonly found in marine and plant oils, may have more potential as neuroprotectants because they affect multiple biochemical processes in the brain that are disturbed by stroke, said the study's … Continue reading

Posted in Brain Injury Treatment | Comments Off on Fish oil may help protect brain after stroke

Hypothermia May Benefit Brain Injury Victims

Posted: Published on February 21st, 2013

Posted by John McKigganFebruary 20, 2013 1:00 PM Who would have thought suffering hypothermia could be a good thing? Recent research from the University of Edinburgh has shown it could potentially save lives and prevent brain damage. What is Hypothermia? Hypothermia occurs when the core body temperature drops below the levels required for the bodily to function. As the body temperature drops below these levels, the physiological systems shut down and the heart rate, respiratory rate and blood pressure decrease. This is not usually a good thing. However, for patients suffering from traumatic brain injuries, inducing hypothermia can have the effect of reducing damage to the brain. The New England Journal of Medicine reports on a controlled study in which 155 patients with head injuries were treated. Of the 155 patients, 82 were treated with hypothermia within 6-hours after the injury. The study concluded that treatment with moderate hypothermia for a period of 24 hours, initiated soon after the injury, significantly improved the outcomes in patients with certain injuries. Doesn't Work in All Cases While studies have shown that inducing hypothermia may improve the outcomes for patients who have suffered traumatic brain injuries, it appears that the results depend on … Continue reading

Posted in Brain Injury Treatment | Comments Off on Hypothermia May Benefit Brain Injury Victims

Page 5,677«..1020..5,6765,6775,6785,679..5,6905,700..»